Cargando…
Next‐Generation Cancer‐Specific Hybrid Theranostic Nanomaterials: MAGE‐A3 NIR Persistent Luminescence Nanoparticles Conjugated to Afatinib for In Situ Suppression of Lung Adenocarcinoma Growth and Metastasis
The rate of lung cancer has gradually increased in recent years, with an average annual increase of 15%. Afatinib (AFT) plays a key role in preventing non‐small cell lung carcinoma (NSCLC) growth and spread. To increase the efficiency of drug loading and NSCLC cell tracking, near infrared‐persistent...
Autores principales: | Chan, Ming‐Hsien, Huang, Wen‐Tse, Wang, Jing, Liu, Ru‐Shi, Hsiao, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201263/ https://www.ncbi.nlm.nih.gov/pubmed/32382487 http://dx.doi.org/10.1002/advs.201903741 |
Ejemplares similares
-
Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics
por: Chan, Ming-Hsien, et al.
Publicado: (2022) -
Conjugated polymer nanomaterials for theranostics
por: Qian, Cheng-gen, et al.
Publicado: (2017) -
Persistent luminescence nanoparticles for cancer theranostics application
por: Liu, Nian, et al.
Publicado: (2021) -
Progress on carbon dots and hydroxyapatite based biocompatible luminescent nanomaterials for cancer theranostics
por: Sengar, Prakhar, et al.
Publicado: (2022) -
Editorial: Theranostic nanomaterials
por: Chen, Wansong, et al.
Publicado: (2023)